Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP773521.RApInGV07Mmr0hjz-1XA0qHhocH6kHsyvSbvIubmOsncI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP773521.RApInGV07Mmr0hjz-1XA0qHhocH6kHsyvSbvIubmOsncI130_assertion type Assertion NP773521.RApInGV07Mmr0hjz-1XA0qHhocH6kHsyvSbvIubmOsncI130_head.
- NP773521.RApInGV07Mmr0hjz-1XA0qHhocH6kHsyvSbvIubmOsncI130_assertion description "[Twenty-seven (24 male and 3 female, mean age 34+/-8 years) renal transplant recipients with erythrocytosis were treated either with E (15 patients) (10 mg/day) or L (12 patients) (50 mg/day) for 8 weeks.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP773521.RApInGV07Mmr0hjz-1XA0qHhocH6kHsyvSbvIubmOsncI130_provenance.
- NP773521.RApInGV07Mmr0hjz-1XA0qHhocH6kHsyvSbvIubmOsncI130_assertion evidence source_evidence_literature NP773521.RApInGV07Mmr0hjz-1XA0qHhocH6kHsyvSbvIubmOsncI130_provenance.
- NP773521.RApInGV07Mmr0hjz-1XA0qHhocH6kHsyvSbvIubmOsncI130_assertion SIO_000772 11502994 NP773521.RApInGV07Mmr0hjz-1XA0qHhocH6kHsyvSbvIubmOsncI130_provenance.
- NP773521.RApInGV07Mmr0hjz-1XA0qHhocH6kHsyvSbvIubmOsncI130_assertion wasDerivedFrom befree-20140225 NP773521.RApInGV07Mmr0hjz-1XA0qHhocH6kHsyvSbvIubmOsncI130_provenance.
- NP773521.RApInGV07Mmr0hjz-1XA0qHhocH6kHsyvSbvIubmOsncI130_assertion wasGeneratedBy ECO_0000203 NP773521.RApInGV07Mmr0hjz-1XA0qHhocH6kHsyvSbvIubmOsncI130_provenance.